Trials / Completed
CompletedNCT05202470
Effectiveness of Telehealth Program in Patients With Type 2 Diabetes
Effectiveness of Telehealth Program in Patients With Type 2 Diabetes: Randomized Controlled Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Muğla Sıtkı Koçman University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Diabetes education is of great importance in the effective management of diabetes. Studies have shown that patients given diabetes education have positive developments in their ability to manage the disease and their attitudes towards the disease. The aim of the study is to compare the education given to individuals with Type 2 diabetes via mobile phone and the education given to individuals via brochures with conventional methods.
Detailed description
The use of telehealth technologies in the field of health is becoming more and more widespread. Telehealth has become one of the frequently used options in the follow-up process of chronic diseases such as diabetes, especially in recent years. Diabetes education is of great importance in the effective management of diabetes. Studies have shown that patients given diabetes education have positive developments in their ability to manage the disease and their attitudes towards the disease. The aim of the study is to compare the education given to individuals with Type 2 diabetes via mobile phone and the education given to individuals via brochures with conventional methods.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | TE | After the first meeting, diabetes education videos prepared in two parts a week will be sent to the mobile phones of the individuals. The video submission will be completed in a total of four weeks. |
| OTHER | CE | After the first meeting, diabetes education videos prepared in two parts a week will be sent to the mobile phones of the individuals. The video submission will be completed in a total of four weeks. |
Timeline
- Start date
- 2022-01-06
- Primary completion
- 2023-05-10
- Completion
- 2023-05-15
- First posted
- 2022-01-21
- Last updated
- 2023-06-15
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05202470. Inclusion in this directory is not an endorsement.